420 investor

Halloween is prime spooky season, but for most investors, all of 2022 has been quite scary. Stocks across the board have taken substantial hits this year, with cannabis particularly affected. Cannabis' surging pandemic performances have been dashed mostly. Now, Fed uncertainty looms while...

"420 Investor" Alan Brochstein has a simple message to CannTrust Holdings Inc (NYSE: CTC) CEO Peter Aceto: apologize for violating Health Canada rules and resign. What Happened CannTrust said in a press release Monday that it "accepted" a Health Canada finding that some of its...

Alan Brochstein, author of "420 Investor" and founding partner of New Cannabis Ventures, appeared on Benzinga's PreMarket Prep show Friday morning and explained why he likes Alcanna Inc (OTC: LQSIF). What Happened Brochstein discussed why Alcanna, a Western Canada-based retailer of...

Investors in GW Pharmaceuticals PLC (NASDAQ: GWPH) may need to sit through some short-term volatility as sales of the company's newly approved drug ramp up slowly because of insurance coverage issues, says the author of The 420 Investor. Alan Brochstein, who is a founding partner of New...

On Thursday, yet another analyst joined the growing chorus saying marijuana stock valuations are getting overheated.  The Analyst Northland Capital Markets analyst Mike Grondahl downgraded Tilray Inc (NASDAQ: TLRY) from Outperform to Market Perform and removed its $60 price target. The Thesis...

Cannabis stocks were again smoking Wednesday after Cronos Group Inc (NASDAQ: CRON) announced a partnership with Ginkgo Bioworks before to produce cannabinoids at scale. Analysts are optimistic about the future for the marijuana industry, but even cannabis bulls are increasingly skeptical of market...

Cannabinoid drug developer GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) is ending an eventful 2016 on a high note. Shares were surging higher by 6.6 percent on Monday following new drug data out over the weekend and a strong fiscal Q4 earnings report out Monday. Over the weekend, the company reported...

The surprise election of Donald Trump has gotten most of the election-related headlines following Tuesday’s vote. However, Tuesday was also a landmark day for the marijuana legalization movement. Marijuana scored medical and/or recreational victories in eight of the nine states that voted on...

Marijuana stocks have been on the rise ahead of legalization initiatives on ballots in nine states in November. However, a number of stocks have not participated in the rally. With nearly every marijuana stock trading on the oft-dangerous over-the-counter markets, it can be difficult to...

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a developer of cannabinoid prescription medicines, spiked by more than 10 percent Monday morning following the company's announcement that Epidiolex achieved a primary endpoint in a Phase 3 clinical study. Epidiolex, GW Pharma's lead...

Happy 420! Even though marijuana is not legal at the federal level, those interested in taking part in Wacky Weed Day's festivities can do so through investing. On Wednesday, Benzinga's PreMarket Prep hosts Joel Elconin and Dennis Dick were joined by Alan Brochstein, the "420...

April 20 of each year marks a celebration for marijuana enthusiasts, despite the herb still being illegal in most of the country. For investors, what this means is until marijuana becomes legalized at the federal level, you'll be hard pressed to find many pot stocks trading in New York....

Shares of GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) are up nearly 120 percent in early Monday trading after the company announced positive Phase III data on Epidiolex. The study found that the drug significantly reduced seizures in children suffering from Dravet Syndrome, a condition for which...

Benzinga spoke with Alan Brochstein, founder of 420 Investor, earlier this week at the Cannabis Business Summit in Denver. Brochstein shared his insights about the burgeoning marijuana industry and the future of publicly-traded stocks within the sector. In the second and final part of this...

Benzinga caught up with Alan Brochstein, founder of 420 Investor, at the Cannabis Business Summit in Denver on Tuesday. And we asked him his thoughts on a variety of issues. Your overall impression of the summit here in Denver? This is their first national convention, and it really says a lot...